Literature DB >> 9069143

Analysis of complications of endoscopic sphincterotomy for biliary stones in a consecutive series of 546 patients.

R Coppola1, M E Riccioni, S Ciletti, L Cosentino, C Coco, P Magistrelli, A Picciocchi.   

Abstract

BACKGROUND: Endoscopic sphincterotomy (ES) plays an important role in treatment of biliary stones; however, there remain some controversies concerning complications of ES, which in most cases seem not to be predictable.
METHODS: The aim of this study was a retrospective analysis of complications in 546 consecutive patients (267 males, 279 females, average age 63.7 years) who underwent endoscopic retrograde cholangiography (ERCP) for biliary stones from 1988 to 1995.
RESULTS: ES was performed in 535 patients (98%), and extraction of stones was successful in 493 (92%). In all, 29 complications (5.4%) were observed, including bleeding 13, cholangitis seven, cholecystitis four, pancreatitis three, retroduodenal perforation two; of these, four (14%) required an operation. Overall mortality was 0.3%.
CONCLUSION: While a significant decrease of the incidence of complications was observed in the course of the study, due to constantly improving experience, no correlation between risk factors and complications was identified.

Entities:  

Mesh:

Year:  1997        PMID: 9069143     DOI: 10.1007/s004649900314

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  11 in total

1.  Intraoperative cholangiography is still indicated after preoperative endoscopic cholangiography for gallstone disease.

Authors:  M Edye; A Dalvi; J Canin-Endres; E Baskin-Bey; B Salky
Journal:  Surg Endosc       Date:  2002-02-08       Impact factor: 4.584

2.  Laparoscopic management of common bile duct stones.

Authors:  S Ebner; J Rechner; S Beller; K Erhart; F M Riegler; G Szinicz
Journal:  Surg Endosc       Date:  2004-02-02       Impact factor: 4.584

Review 3.  Primary closure versus T-tube drainage in laparoscopic common bile duct exploration: a meta-analysis of randomized clinical trials.

Authors:  Xiangsong Wu; Yong Yang; Ping Dong; Jun Gu; Jianhua Lu; Maolan Li; Jiasheng Mu; Wenguang Wu; Jiahua Yang; Lin Zhang; Qichen Ding; Yingbin Liu
Journal:  Langenbecks Arch Surg       Date:  2012-05-29       Impact factor: 3.445

4.  [Therapeutic splitting as standard treatment for cholelithiasis].

Authors:  U T Hopt; U Adam
Journal:  Chirurg       Date:  2006-04       Impact factor: 0.955

5.  Evaluation of laparoscopic treatment of common bile duct stones in a prospective series of 505 patients: indications and results.

Authors:  J Ch Berthou; B Dron; Ph Charbonneau; K Moussalier; L Pellissier
Journal:  Surg Endosc       Date:  2007-05-24       Impact factor: 4.584

6.  Stone clearance and risk factors for failure in laparoscopic transcystic exploration of the common bile duct.

Authors:  Cecilia Strömberg; Magnus Nilsson; Carl-Eric Leijonmarck
Journal:  Surg Endosc       Date:  2008-05       Impact factor: 4.584

Review 7.  Systematic review with meta-analysis of studies comparing primary duct closure and T-tube drainage after laparoscopic common bile duct exploration for choledocholithiasis.

Authors:  Mauro Podda; Francesco Maria Polignano; Andreas Luhmann; Michael Samuel James Wilson; Christoph Kulli; Iain Stephen Tait
Journal:  Surg Endosc       Date:  2015-06-20       Impact factor: 4.584

Review 8.  Value of temporary stents for the management of perivaterian perforation during endoscopic retrograde cholangiopancreatography.

Authors:  Sang Min Lee; Kwang Bum Cho
Journal:  World J Clin Cases       Date:  2014-11-16       Impact factor: 1.337

9.  Long-term prognosis after treatment of patients with choledocholithiasis.

Authors:  Kazuhisa Uchiyama; Hironobu Onishi; Masaji Tani; Hiroyuki Kinoshita; Manabu Kawai; Masaki Ueno; Hiroki Yamaue
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

10.  Long-term symptoms following endoscopic sphincterotomy for common bile duct stones.

Authors:  R C A Macadam; R J R Goodall
Journal:  Surg Endosc       Date:  2004-01-14       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.